Table 1.

Characteristics of study participants, stratified by presence of sarcopenia.

	Sarcopenia [n = 57] [N%]	No sarcopenia [n = 25] [N%]	p-value
Age	41 ± 28	32 ± 16	0.40††
Gender			0.002
Male	43 [75.4%]	10 [40%]
Female	14 [24.6%]	15 [60%]
Pancolitis	27 [47.4%]	13 [52%]	0.70
Disease duration [years]	2 ± 7	3.5 ± 4.5	0.28††
Body mass index [BMI]	23 ± 6	26 ± 8	0.02††
Smoking [n = 25]			0.847†
Never	7 [43.8%]	5 [55.6%]
Smoker	2 [12.5%]	1 [11.1%]
Past smoker	7 [43.8%]	3 [33.3%]
Severe endoscopic disease [n = 63]	24 [58.5%]	13 [59.1%]	0.97
Prior biologics	17 [29.8%]	9 [36%]	0.58
Prior mesalamines	52 [91.2%]	21 [84%]	0.45†
Prior immunomodulators	20 [35.1%]	13 [52%]	0.15
Albumin [in g/dL]	3.4 ± 0.6	3.5 ± 0.6	0.64
C-reactive protein [in mg/L]	50 ± 76	34 ± 63.2	0.51††
CRP/albumin	1.4 ± 2.7	1.1 ± 2.3	0.53††
Hemoglobin [in g/dL]	11.4 ± 2.5	11.3 ± 2.4	0.83
ESR [in mm/h]	37 ± 42	42.5 ± 29.1	0.73††
Length of stay [in days]	10 ± 9	8 ± 7	0.10††

† Fishers exact test

†† Wilcoxon Rank Sum Test